Drugs, Ethics, and Quality of Life: Cases and Materials on Ethical, Legal, and Public Policy Dilemmas in Medicine and Pharmacy Practice

Drugs, Ethics, and Quality of Life: Cases and Materials on Ethical, Legal, and Public Policy Dilemmas in Medicine and Pharmacy Practice

by Bruce White
     
 

ISBN-10: 0789028565

ISBN-13: 9780789028563

Pub. Date: 12/28/2007

Publisher: Taylor & Francis

Weighing the ethical considerations in healthcare and drug issues can be emotionally difficult and mentally challenging. Drugs, Ethics, and Quality of Life: Cases and Materials on Ethical, Legal, and Public Policy Dilemmas in Medicine and Pharmacy Practice is a fascinating casebook that clearly discusses the most contentious ethical conflicts that resulted in

…  See more details below

Overview

Weighing the ethical considerations in healthcare and drug issues can be emotionally difficult and mentally challenging. Drugs, Ethics, and Quality of Life: Cases and Materials on Ethical, Legal, and Public Policy Dilemmas in Medicine and Pharmacy Practice is a fascinating casebook that clearly discusses the most contentious ethical conflicts that resulted in legal actions. This easy-to-read text provides all sides of controversial real-life cases that provoke spirited debate while teaching the fundamentals of pharmacy law and ethics. The book is a unique exploration into the basic principles of bioethics, end of life care, and drug research.

Product Details

ISBN-13:
9780789028563
Publisher:
Taylor & Francis
Publication date:
12/28/2007
Edition description:
New Edition
Pages:
348
Product dimensions:
6.20(w) x 8.60(h) x 1.00(d)

Table of Contents

  • Foreword (Kenneth V. Iserson)
  • Preface
  • Acknowledgments
  • Introduction: Pellegrino on Professionalism: A Human Values Basis for the Healing Arts
  • Appendix: Principles of Medical Ethics of the American Medical Association (2001)
  • Special Additional Introduction: Ethics and a Code of Ethics in Pharmacy Practice (Joseph L. Fink III)
  • Appendix: Code of Ethics for Pharmacists of the American Pharmacists Association (1994)
  • PART I: FOUNDATIONAL BASICS
  • Chapter 1. Tobacco and Choices: How Values and Definitions Impact Decision Making
  • FDA’s 1996 Tobacco Regulations and FDA v. Brown & Williamson
  • Definitions
  • Continuing Dilemmas with Tobacco
  • Chapter 2. COX-2 Inhibitors and Conflict: How Balancing Beneficence and Nonmaleficence Influences Decision Making
  • COX-2 Inhibitors and Their Effects
  • The FDA’s Drug Approval Process and VIOXX
  • A Balancing Act: Beneficence, Nonmaleficence, and Profit and Other Motives
  • Cost-Benefit Analysis, Stakeholders, and Issues Management Analysis
  • Continuing Dilemmas with COX-2 Inhibitors
  • Chapter 3. Marijuana, Individual Liberty, and Police Power: How Autonomy Drives Decision Making
  • Marijuana
  • Marijuana Control in the United States
  • Personal Freedom, Autonomy, and the California Compassionate Use Act
  • State Police Power and Federalism: Gonzales v. Raich
  • Continuing Dilemmas with Medical Marijuana
  • Appendix: Examples of California’s Criminal Statutes Controlling Marijuana Calif. Health & Safety Code §§ 11357 and 11358
  • Chapter 4. The "Morning-After" Pill and Systematic Ethics and Public Policy Analysis: How Justice Tempers Decision Making
  • Emergency Contraceptives and Rights
  • Balancing "Rights": Ethics and Public Policy
  • Justice and Conscientious Objection
  • Conflict and Systematic Ethical Analysis
  • Continuing Dilemmas with Emergency Contraceptives
  • PART II: PAIN MEDICINES AND END-OF-LIFE DRUGS
  • Chapter 5. Pain Medicines and Palliative Care Drugs
  • Bergman v. Chin
  • When Will Adequate Pain Control Be the Norm?
  • Continuing Dilemmas with Pain Medicines and Palliative Care Drugs
  • Chapter 6. Drugs Used for Assisted Suicide
  • The Debate about Physician-Assisted Suicide and Euthanasia
  • The Oregon Death with Dignity Act
  • Continuing Dilemmas with Assisted Suicide and Euthanasia
  • Chapter 7. Drug Use in "Dwindling" Patients and in Medically Futile Situations
  • "Dwindling" Patients and Quality of Life
  • Medical Futility
  • Surrogate Medical Decision Making
  • Continuing Dilemmas Involving Drug Use in "Dwindling" Patients and Medically Futile Situations
  • Appendix: Tennessee Health Care Decisions Act (2004)
  • PART III: DRUG EXPERIMENTATION
  • Chapter 8. Gene Therapy and Experimentation
  • The Federal Drug Research and Patient Safety Framework
  • Gelsinger v. University of Pennsylvania
  • Continuing Dilemmas with Gene Therapy and Experimentation
  • Afterword (John Lachs)
  • Appendix 1. Law and Decisions
  • Objectives
  • What Does Law Mean?
  • What Are the Four Primary Sources of Law in the United States?
  • How Do the People (The Nation’s Citizens) Create Law?
  • How Do Legislative Bodies Create Law?
  • How Do Federal and State Administrative Agencies Create Law?
  • How Do Federal and State Judges Create Law?
  • Appendix 2. Continuing Dilemmas Involving Drugs, Ethics, and Quality of Life: An Outline for Further Discussion
  • Topics Related to Drug Use
  • Topics Related to Professional Virtues
  • Notes
  • Index

Read More

Customer Reviews

Average Review:

Write a Review

and post it to your social network

     

Most Helpful Customer Reviews

See all customer reviews >